Background: 5-aminosalicylic acid (5-ASA, mesalamine) is at present the treatment of choice for Inflammatory Bowel Diseases (IBD), with a therapeutic regimen of 2.4-4.8 g/day. However, most of the mesalamine-based products currently available on the market contain a dose of 5-ASA (generally 500 mg API/unit) which is relatively low if considering the aforementioned dosage regimen. A high strength dosage form containing more than 1 g 5-ASA would therefore be of interest to reduce daily administrations and hence improving compliance. Multi-particulates dosage forms, based on high density pellets, have been sought as promising alternatives for the administration of 5-ASA, both for their biopharmaceutical (e.g. more even and predictable distribu...
The present research is a challenge to design, optimized and evaluates mesalamine loaded burst relea...
Mesalazine (5-ASA) is an anti-inflammatory drug used for ulcerative colitis or Crohn's desease. Most...
Objective: The present work was aimed at preparation of mesalazine microspheres by a non-aqueous sol...
Purpose: To develop an oral multi-particulate drug delivery system (DDS) containing a high dose (i.e...
Purpose. 5-aminosalicylic acid (5-ASA) has demonstrated its potential to treat IBD (Inflammatory Bow...
Pellets with high loading of 5-aminosalicylic acid (5-ASA, mesalamine) are desired to reduce the num...
Purpose: To develop an oral multi-particulate drug delivery system (DDS) containing a high dose (i.e...
The aim of the current work was to develop an extrusion-spheronisation (E-S) route to manufacture pe...
Objective: The aim of the present work was to develop new solid pharmaceutical delivery systems of m...
Objective: The aim of the present work was to develop new solid pharmaceutical delivery systems of m...
The present work describes a study on “Formulation and Characterization of Mesalamine pellets” Mesa...
The present research is a challenge to design, optimized and evaluates mesalamine loaded burst relea...
Mesalazine (5-ASA) is the standard drug for the treatment of inflammatory bowel disease (IBD) due to...
Objective: This study was intended to investigate the potential of the colon specificity approach co...
Objective: This study was intended to investigate the potential of the colon specificity approach co...
The present research is a challenge to design, optimized and evaluates mesalamine loaded burst relea...
Mesalazine (5-ASA) is an anti-inflammatory drug used for ulcerative colitis or Crohn's desease. Most...
Objective: The present work was aimed at preparation of mesalazine microspheres by a non-aqueous sol...
Purpose: To develop an oral multi-particulate drug delivery system (DDS) containing a high dose (i.e...
Purpose. 5-aminosalicylic acid (5-ASA) has demonstrated its potential to treat IBD (Inflammatory Bow...
Pellets with high loading of 5-aminosalicylic acid (5-ASA, mesalamine) are desired to reduce the num...
Purpose: To develop an oral multi-particulate drug delivery system (DDS) containing a high dose (i.e...
The aim of the current work was to develop an extrusion-spheronisation (E-S) route to manufacture pe...
Objective: The aim of the present work was to develop new solid pharmaceutical delivery systems of m...
Objective: The aim of the present work was to develop new solid pharmaceutical delivery systems of m...
The present work describes a study on “Formulation and Characterization of Mesalamine pellets” Mesa...
The present research is a challenge to design, optimized and evaluates mesalamine loaded burst relea...
Mesalazine (5-ASA) is the standard drug for the treatment of inflammatory bowel disease (IBD) due to...
Objective: This study was intended to investigate the potential of the colon specificity approach co...
Objective: This study was intended to investigate the potential of the colon specificity approach co...
The present research is a challenge to design, optimized and evaluates mesalamine loaded burst relea...
Mesalazine (5-ASA) is an anti-inflammatory drug used for ulcerative colitis or Crohn's desease. Most...
Objective: The present work was aimed at preparation of mesalazine microspheres by a non-aqueous sol...